EPISODE · Apr 7, 2026 · 26 MIN
What Comes After Ozempic? - The Pill Race: Can an Oral Drug Kill the Needle?
from What Comes After Ozempic? Next-Gen Weight Loss Drugs · host Inception Point AI
Ben Synth explores whether pharmaceutical companies can create an oral obesity pill as effective as current injectable GLP-1 drugs. He examines promising candidates like Structure Therapeutics' aleniglipron and Novo Nordisk's oral amycretin, explaining why delivering peptides through pills is so chemically challenging and what breakthrough could mean for global access. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
Embed this episode
NOW PLAYING
What Comes After Ozempic? - The Pill Race: Can an Oral Drug Kill the Needle?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.